ROYCE & ASSOCIATES LP - 31 Dec 2025 SCHEDULE 13G/A Report for Apyx Medical Corporation Common Stock (APYX)

Filing Manager: ROYCE & ASSOCIATES LP
Reporting Manager: ROYCE & ASSOCIATES LP
Security: Apyx Medical Corporation Common Stock
Symbol: APYX
Shares outstanding: 41,059,412 shares
Disclosed Ownership: 2,443,035 shares
Ownership: 6%
Form type: SCHEDULE 13G/A
Filing time: 20 Jan 2026, 10:02:57 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
ROYCE & ASSOCIATES LP	6%	2,443,035	2,443,035	0	Daniel A. O'Byrne	Vice President